miRNA工具及服务市场规模、份额、成长分析（依产品类型、技术、应用、最终用户及地区划分）－2025-2032年产业预测

全球 miRNA 工具和服务市场规模预计在 2023 年达到 3.721 亿美元，从 2024 年的 4.1898 亿美元增长到 2032 年的 10.8269 亿美元，在预测期（2025-2032 年）内复合年增长率为 12.6%。

全球miRNA工具和服务市场正经历强劲成长，这主要得益于慢性病和遗传性疾病盛行率的上升，以及製药和生技产业研发投入的增加。政府的利好政策和分子生物学技术的进步正在提高这些工具和服务的准确性和可负担性。受託研究机构的蓬勃发展为优化成本和克服技术难题提供了契机。生命科学领域的合作倡议和数据共用也促进了这些工具的普及。此外，人们逐渐认识到miRNA在农业和兽医学领域的重要性，这正在扩大其应用范围。人工智慧、机器学习、物联网、扩增实境和虚拟实境技术的融合，透过改进数据分析、监管合规以及教育培训，正在革新整个市场。

推动全球miRNA工具与服务市场发展的因素

全球miRNA工具和服务市场的主要驱动因素之一是慢性疾病的日益普遍，这推动了个人化医疗的研究与发展。 miRNA在基因表现和调控中发挥关键作用，因此对其进行分析和鑑定对于阐明疾病机制和开发标靶治疗至关重要。对先进诊断工具和治疗方案日益增长的需求正在推动miRNA研究领域的投资，进而促进技术创新和miRNA工具及服务的扩展。因此，这一趋势正在促进学术机构、生技公司和製药公司之间的合作，进而提升市场潜力。

限制全球miRNA工具与服务市场的因素

全球miRNA工具和服务市场的主要限制因素之一是先进定序技术和miRNA分析所需专用设备的高成本。这些成本对中小型实验室和研究机构构成障碍，限制了它们投资先进miRNA工具和服务的能力。此外，数据解读的复杂性以及对分析和检验结果的专业人员的需求，进一步增加了部分相关人员的进入难度。这些经济负担可能会阻碍miRNA技术的创新和广泛应用，最终减缓市场成长和发展。

全球miRNA工具与服务市场趋势

全球miRNA工具和服务市场正呈现显着成长趋势，其在诊断应用的应用日益广泛，尤其是在心血管疾病、神经系统疾病和感染疾病。非侵入性诊断方法的兴起推动了对miRNA工具和服务精准性的需求。同时，各国政府加强加强医疗基础建设，并提供miRNA研究的津贴和激励措施，这些措施也促进了miRNA服务在临床环境中更广泛的应用和整合。技术创新、医疗需求和扶持政策的共同作用，预计将推动miRNA工具市场在诊断行业持续成长和扩张。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球miRNA工具及服务市场规模（依产品类型及复合年增长率划分）（2025-2032年）

• 市场概览
• miRNA表现分析
• miRNA的分离与纯化
• miRNA定序
• miRNA抑制剂
• miRNA模拟物

全球miRNA工具及服务市场规模（依技术及复合年增长率划分）（2025-2032年）

• 市场概览
• 微阵列
• 定量PCR
• 下一代定序
• Northern印迹法

全球miRNA工具及服务市场规模（依应用及复合年增长率划分）（2025-2032年）

• 市场概览
• 研究
• 诊断
• 治疗药物
• 农业

全球 miRNA 工具及服务市场规模（依最终用户划分）、复合年增长率 (2025-2032)

• 市场概览
• 学术和研究机构
• 生技公司
• 製药公司
• 受託研究机构

miRNA 工具及服务全球市场规模及复合年增长率（2025-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• Thermo Fisher Scientific, Inc.（United States）
• QIAGEN NV（Netherlands）
• Illumina, Inc.（United States）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• Takara Bio, Inc.（Japan）
• PerkinElmer, Inc.（United States）
• New England Biolabs, Inc.（NEB）（United States）
• NanoString Technologies, Inc.（United States）
• Abcam plc（United Kingdom）
• GeneCopoeia, Inc.（United States）
• OriGene Technologies, Inc.（United States）
• Promega Corporation（United States）
• Norgen Biotek Corp.（Canada）
• Integrated DNA Technologies, Inc.（IDT）（United States）
• LGC Limited（United Kingdom）
• Horizon Discovery Group plc（United Kingdom）
• System Biosciences（SBI）（United States）
• Eurofins Scientific SE（Luxembourg）

结论与建议

Global MiRNA Tools Services Market size was valued at USD 372.1 million in 2023 and is poised to grow from USD 418.98 million in 2024 to USD 1082.69 million by 2032, growing at a CAGR of 12.6% during the forecast period (2025-2032).

The global miRNA tools and services market is experiencing robust growth driven by the increasing incidence of chronic and genetic diseases, alongside heightened investments in research and development from pharmaceutical and biotech sectors. Favorable government policies and technological advancements in molecular biology enhance the precision and affordability of these tools and services. The proliferation of contract research organizations presents opportunities to optimize costs and navigate technical hurdles. Collaborative initiatives and data sharing in life sciences enhance the accessibility of these tools. Additionally, awareness of miRNA's significance in agriculture and veterinary sciences broadens its application. Furthermore, the integration of AI, machine learning, IoT, augmented reality, and virtual reality is revolutionizing the market by improving data analysis, regulatory compliance, and educational training.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MiRNA Tools Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MiRNA Tools Services Market Segments Analysis

Global MiRNA Tools Services Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into miRNA Expression Analysis, miRNA Isolation and Purification, miRNA Sequencing, miRNA Inhibitors and miRNA Mimics. Based on Technology, the market is segmented into Microarray, Quantitative PCR, Next-Generation Sequencing and Northern Blotting. Based on Application, the market is segmented into Research, Diagnostics, Therapeutics and Agriculture. Based on End User, the market is segmented into Academic and Research Institutions, Biotechnology Companies, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MiRNA Tools Services Market

One key market driver for the Global miRNA Tools Services Market is the increasing prevalence of chronic diseases, which has spurred research and development in personalized medicine. As miRNAs are recognized for their critical roles in gene expression and regulation, their profiling and analysis have become essential for understanding disease mechanisms and developing targeted therapies. The growing demand for advanced diagnostic tools and therapeutic solutions is prompting investments in miRNA research, which further drives innovation and expansion in miRNA tools and services. Consequently, this trend enhances the market's potential by fostering collaborations between academic institutions, biotechnology firms, and pharmaceutical companies.

Restraints in the Global MiRNA Tools Services Market

One key market restraint for the global miRNA tools services market is the high cost associated with advanced sequencing technologies and specialized equipment required for miRNA analysis. These costs can be a barrier for small and medium-sized laboratories and research institutions, limiting their ability to invest in sophisticated miRNA tools and services. Additionally, the complexity of data interpretation and the need for skilled personnel to analyze and validate results further complicate market access for some stakeholders. This financial burden may hinder innovation and wider adoption of miRNA technologies, ultimately slowing down market growth and development.

Market Trends of the Global MiRNA Tools Services Market

The Global miRNA Tools Services market is experiencing a notable trend toward increased adoption in diagnostic applications, particularly for cardiovascular diseases, neurological disorders, and infectious diseases. The shift toward non-invasive diagnostic methods is driving demand for the precise and accurate capabilities of miRNA tools and services. Alongside this, enhanced government initiatives aimed at bolstering healthcare infrastructure-coupled with grants and incentives for miRNA research-are catalyzing a broader acceptance and integration of these services in clinical settings. This convergence of technological innovation, healthcare demand, and supportive policies positions the miRNA tools market for sustained growth and expansion in the diagnostics landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global MiRNA Tools Services Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• miRNA Expression Analysis
• miRNA Isolation and Purification
• miRNA Sequencing
• miRNA Inhibitors
• miRNA Mimics

Global MiRNA Tools Services Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Microarray
• Quantitative PCR
• Next-Generation Sequencing
• Northern Blotting

Global MiRNA Tools Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research
• Diagnostics
• Therapeutics
• Agriculture

Global MiRNA Tools Services Market Size by End User & CAGR (2025-2032)

• Market Overview
• Academic and Research Institutions
• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organizations

Global MiRNA Tools Services Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (NEB) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (IDT) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (SBI) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations